Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: Definitive results of a randomized study (55872) by the EORTC Gynaecological Cancer Group

MS Aapro; Heidy Wijk; G Bolis; B Chevallier; MEL Burg; A Poveda; J Oliveira; S Tumolo; V Scotto di Palumbo; M Piccart; M Franchi; F Zanaboni; AJ Lacave; R Fontanelli; G Favalli; P Zola; JP Guastalla; R Rosso; C Marth; M Nooij; M Presti; C Scarabelli; Ted Splinter; E Ploch; LVAM Beex; WW ten Bokkel Huinink; M Forni; M Melpignano; P Blake; P Kerbrat; C Mendiola; A Cervantes; A Goupil; PG Harper; C Madronal; M Namer; G Scarfone; JEGM Stoot; I Teodorovic; C Coens; I Vergote; JB Vermorken

doi:10.1093/annonc/mdg112

Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: Definitive results of a randomized study (55872) by the EORTC Gynaecological Cancer Group

MS Aapro, Heidy Wijk, G Bolis, B Chevallier, MEL Burg, A Poveda, J Oliveira, S Tumolo, V Scotto di Palumbo, M Piccart, M Franchi, F Zanaboni, AJ Lacave, R Fontanelli, G Favalli, P Zola, JP Guastalla, R Rosso, C Marth, M NooijM Presti, C Scarabelli, Ted Splinter, E Ploch, LVAM Beex, WW ten Bokkel Huinink, M Forni, M Melpignano, P Blake, P Kerbrat, C Mendiola, A Cervantes, A Goupil, PG Harper, C Madronal, M Namer, G Scarfone, JEGM Stoot, I Teodorovic, C Coens, I Vergote, JB Vermorken

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

184 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	441-448
Number of pages	8
Journal	Annals of Oncology
Volume	14
DOIs	https://doi.org/10.1093/annonc/mdg112
Publication status	Published - 2003

Research programs

EMC MM-03-86-08

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdg112

http://hdl.handle.net/1765/66299

Cite this

Aapro, MS., Wijk, H., Bolis, G., Chevallier, B., Burg, MEL., Poveda, A., Oliveira, J., Tumolo, S., Scotto di Palumbo, V., Piccart, M., Franchi, M., Zanaboni, F., Lacave, AJ., Fontanelli, R., Favalli, G., Zola, P., Guastalla, JP., Rosso, R., Marth, C., ... Vermorken, JB. (2003). Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: Definitive results of a randomized study (55872) by the EORTC Gynaecological Cancer Group. Annals of Oncology, 14, 441-448. https://doi.org/10.1093/annonc/mdg112

@article{cc72b23cf44a4435ba566a17dec2196f,

title = "Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: Definitive results of a randomized study (55872) by the EORTC Gynaecological Cancer Group",

author = "MS Aapro and Heidy Wijk and G Bolis and B Chevallier and MEL Burg and A Poveda and J Oliveira and S Tumolo and {Scotto di Palumbo}, V and M Piccart and M Franchi and F Zanaboni and AJ Lacave and R Fontanelli and G Favalli and P Zola and JP Guastalla and R Rosso and C Marth and M Nooij and M Presti and C Scarabelli and Ted Splinter and E Ploch and LVAM Beex and {ten Bokkel Huinink}, WW and M Forni and M Melpignano and P Blake and P Kerbrat and C Mendiola and A Cervantes and A Goupil and PG Harper and C Madronal and M Namer and G Scarfone and JEGM Stoot and I Teodorovic and C Coens and I Vergote and JB Vermorken",

year = "2003",

doi = "10.1093/annonc/mdg112",

language = "Undefined/Unknown",

volume = "14",

pages = "441--448",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

}

Aapro, MS, Wijk, H, Bolis, G, Chevallier, B, Burg, MEL, Poveda, A, Oliveira, J, Tumolo, S, Scotto di Palumbo, V, Piccart, M, Franchi, M, Zanaboni, F, Lacave, AJ, Fontanelli, R, Favalli, G, Zola, P, Guastalla, JP, Rosso, R, Marth, C, Nooij, M, Presti, M, Scarabelli, C, Splinter, T, Ploch, E, Beex, LVAM, ten Bokkel Huinink, WW, Forni, M, Melpignano, M, Blake, P, Kerbrat, P, Mendiola, C, Cervantes, A, Goupil, A, Harper, PG, Madronal, C, Namer, M, Scarfone, G, Stoot, JEGM, Teodorovic, I, Coens, C, Vergote, I & Vermorken, JB 2003, 'Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: Definitive results of a randomized study (55872) by the EORTC Gynaecological Cancer Group', Annals of Oncology, vol. 14, pp. 441-448. https://doi.org/10.1093/annonc/mdg112

TY - JOUR

T1 - Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: Definitive results of a randomized study (55872) by the EORTC Gynaecological Cancer Group

AU - Aapro, MS

AU - Wijk, Heidy

AU - Bolis, G

AU - Chevallier, B

AU - Burg, MEL

AU - Poveda, A

AU - Oliveira, J

AU - Tumolo, S

AU - Scotto di Palumbo, V

AU - Piccart, M

AU - Franchi, M

AU - Zanaboni, F

AU - Lacave, AJ

AU - Fontanelli, R

AU - Favalli, G

AU - Zola, P

AU - Guastalla, JP

AU - Rosso, R

AU - Marth, C

AU - Nooij, M

AU - Presti, M

AU - Scarabelli, C

AU - Splinter, Ted

AU - Ploch, E

AU - Beex, LVAM

AU - ten Bokkel Huinink, WW

AU - Forni, M

AU - Melpignano, M

AU - Blake, P

AU - Kerbrat, P

AU - Mendiola, C

AU - Cervantes, A

AU - Goupil, A

AU - Harper, PG

AU - Madronal, C

AU - Namer, M

AU - Scarfone, G

AU - Stoot, JEGM

AU - Teodorovic, I

AU - Coens, C

AU - Vergote, I

AU - Vermorken, JB

PY - 2003

Y1 - 2003

U2 - 10.1093/annonc/mdg112

DO - 10.1093/annonc/mdg112

M3 - Article

SN - 0923-7534

VL - 14

SP - 441

EP - 448

JO - Annals of Oncology

JF - Annals of Oncology

ER -